Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer. uri icon

authors

  • Owen, Dwight H
  • Schweitzer, Catherine
  • Pilcher, Carly
  • Smith, Michael B
  • Ferguson, Sarah
  • Palomino, Julio Castro
  • Pérez, Santiago Figueroa
  • Bertino, Erin M
  • Shields, Peter G
  • He, Kai
  • Carolyn Presley
  • Wu, Ruohan
  • Otterson, Gregory A
  • Carson, William E
  • Carbone, David P
  • Wei, Lai
  • Dikov, Mikhail
  • Suman, Shankar
  • Su, Po-Lan
  • Amann, Joseph
  • Guan, Shuxiao
  • Spakowicz, Daniel

publication date

  • December 3, 2025